130 related articles for article (PubMed ID: 3367133)
1. Serial assay for IGM anti-HBc in patients with anti-HBe-positive chronic hepatitis and its significance for long-term prognosis.
Kiyosawa K; Sodeyama T; Franca ST; Yoda H; Ohike Y; Imai H; Imai Y; Furuta S
J Med Virol; 1988 Mar; 24(3):241-50. PubMed ID: 3367133
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis.
Bortolotti F; Bertaggia A; Rude L; Armigliato M; Crivellaro C; Alberti A; Pornaro E; Realdi G
Eur J Pediatr; 1987 Jul; 146(4):394-7. PubMed ID: 3653136
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and significance of anti-HBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors.
Bänninger P; Altorfer J; Frösner GG; Pirovino M; Gudat F; Bianchi L; Grob PJ; Schmid M
Hepatology; 1983; 3(3):337-42. PubMed ID: 6341197
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
[TBL] [Abstract][Full Text] [Related]
5. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
6. Follow-up studies on IgM anti-HBc during chronic hepatitis B.
Lindenschmidt EG
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Jul; 261(4):461-70. PubMed ID: 3765952
[TBL] [Abstract][Full Text] [Related]
7. [Determination of specific anti-HBO immunoglobulin of IgM or IgG type. Relation to other virus HB markers].
Maniez-Montreuil M; Dupressoir-Burlet MV; Goudemand M
Rev Fr Transfus Immunohematol; 1982 Jun; 25(3):245-63. PubMed ID: 7111979
[TBL] [Abstract][Full Text] [Related]
8. Anti-HBc of IgM-class, HBeAg and anti-HBe in acute and chronic hepatitis B.
Aldershvile J; Roggendorf M; Kryger P; Tage-Jensen U; Deinhardt F; Frösner GG; Hardt F; Nielsen JO
Liver; 1981 Dec; 1(4):290-7. PubMed ID: 7348762
[TBL] [Abstract][Full Text] [Related]
9. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.
Sällberg M; Norder H; Magnius LO
J Med Virol; 1990 Jan; 30(1):1-6. PubMed ID: 2303802
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-HBc IgM following prednisone treatment in patients with chronic active hepatitis B virus infection.
Nowicki MJ; Tong MJ; Nair PV; Stevenson D
Hepatology; 1984; 4(6):1129-33. PubMed ID: 6500508
[TBL] [Abstract][Full Text] [Related]
11. Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.
Tassopoulos NC; Sjogren MH; Ticehurst JR; Engle RE; Roumeliotou-Karayannis A; Gerin JL; Purcell RH; Papaevangelou G
Liver; 1986 Oct; 6(5):275-80. PubMed ID: 3784781
[TBL] [Abstract][Full Text] [Related]
12. [Clinical relevance of immunoglobulin M antibody fraction against hepatitis B core antigen (anti-HBc-IgM) (author's transl)].
Feuerhake A; Wille E; Müller R
Dtsch Med Wochenschr; 1982 Jul; 107(26):1012-4. PubMed ID: 7084068
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection.
Tsuda F; Naito S; Takai E; Akahane Y; Furuta S; Miyakawa Y; Mayumi M
Gastroenterology; 1984 Jul; 87(1):159-64. PubMed ID: 6724259
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus.
Sjogren MH; Lemon SM
J Infect Dis; 1983 Sep; 148(3):445-51. PubMed ID: 6619574
[TBL] [Abstract][Full Text] [Related]
15. Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lai MC; Tong MJ; Nowicki MJ; Lee SD
Hepatology; 1988; 8(3):514-7. PubMed ID: 2453429
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the response time of anti-HBc IgM in a hepatitis B case load. Diagnostic implications].
Cremoni L; Buffa D; Sauco F; Bongetta R; Arosio M; d'Amico P
Boll Ist Sieroter Milan; 1986; 65(5):430-5. PubMed ID: 3828097
[TBL] [Abstract][Full Text] [Related]
18. IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
Sjogren MH; Lemon SM; Chung WK; Sun HS; Hoofnagle JH
Hepatology; 1984; 4(4):615-8. PubMed ID: 6204916
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of anti-HBc and IgM.anti-HBc].
Chen BJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Apr; 10(2):104-9. PubMed ID: 2970316
[No Abstract] [Full Text] [Related]
20. Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen.
Kryger P; Mathiesen LR; Møller AM; Aldershvile J; Hansson BG; Nielsen JO
J Clin Microbiol; 1981 Mar; 13(3):405-9. PubMed ID: 7240384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
